NASDAQ:AIKI AIkido Pharma - AIKI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.50 +0.01 (+0.29%) (As of 03/17/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.43▼$3.6450-Day Range$3.49▼$4.4552-Week Range$3.31▼$11.48Volume24,430 shsAverage Volume79,326 shsMarket Capitalization$19.20 millionP/E RatioN/ADividend YieldN/APrice Target$16.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media AIkido Pharma MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside349.4% Upside$16.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($4.70) to ($1.50) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.63 out of 5 starsMedical Sector726th out of 983 stocksCommercial Physical Research Industry13th out of 16 stocks 3.5 Analyst's Opinion Consensus RatingAIkido Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.00, AIkido Pharma has a forecasted upside of 349.4% from its current price of $3.56.Amount of Analyst CoverageAIkido Pharma has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AIKI. Previous Next 0.0 Dividend Strength Dividend YieldAIkido Pharma does not currently pay a dividend.Dividend GrowthAIkido Pharma does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AIKI. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for AIkido Pharma this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AIkido Pharma insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.60% of the stock of AIkido Pharma is held by insiders.Percentage Held by InstitutionsOnly 10.88% of the stock of AIkido Pharma is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for AIkido Pharma are expected to grow in the coming year, from ($4.70) to ($1.50) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AIkido Pharma is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AIkido Pharma is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAIkido Pharma has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AIkido Pharma (NASDAQ:AIKI) StockAIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.Read More Receive AIKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address AIKI Stock News HeadlinesMarch 14, 2023 | finance.yahoo.comDominari Holdings Provides Business UpdateDecember 28, 2022 | finance.yahoo.comDominari Holdings Provides Update on Share Repurchase ProgramMarch 20, 2023 | Health Sector Insight (Ad)Big Potential, Tiny Penny StockLittle-known stock ready to disrupt the $4.37 trillion wellness marketDecember 22, 2022 | finanznachrichten.deAIkido Pharma Inc.: AIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesDecember 22, 2022 | finance.yahoo.comAIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)November 28, 2022 | finance.yahoo.comAIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesOctober 6, 2022 | finance.yahoo.comAIkido Share Repurchase ContinuesOctober 5, 2022 | finance.yahoo.comAIkido Purchases More SharesMarch 20, 2023 | Health Sector Insight (Ad)Big Potential, Tiny Penny StockLittle-known stock ready to disrupt the $4.37 trillion wellness marketOctober 4, 2022 | finance.yahoo.comShare Repurchase Program ContinuesOctober 3, 2022 | finance.yahoo.comAIkido Pharma Continues Share Repurchase ProgramSeptember 30, 2022 | finance.yahoo.comAIkido Pharma Provides Update on Share Repurchase ProgramAugust 10, 2022 | ca.investing.comPre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for UnityAugust 10, 2022 | marketwatch.comAIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKIAugust 10, 2022 | nasdaq.comAIkido Pharma Receives Offer From Shalom Auerbach - Quick FactsAugust 10, 2022 | finance.yahoo.comAIkido Pharma Confirms Receipt of Unsolicited OfferAugust 9, 2022 | finance.yahoo.comInvestor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in CashAugust 7, 2022 | reuters.comAikido Pharma IncJuly 21, 2022 | finance.yahoo.comAIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services SubsidiaryJune 30, 2022 | seekingalpha.comAIkido Pharma regains Nasdaq complianceJune 24, 2022 | finance.yahoo.comAIkido Inc. Announces the Formation of a New Financial Services SubsidiaryJune 21, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to StockholdersJune 10, 2022 | finance.yahoo.comAIkido Pharma Inc. Appoints New Director, Soo YuJune 9, 2022 | benzinga.comSignificant Investor in AIkido Pharma Issues Open...June 8, 2022 | morningstar.comAIkido Pharma stock falls again after reverse stock split takes effectJune 7, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Issues Open Letter to Board of DirectorsJune 7, 2022 | investorplace.comWhy Is AIkido Pharma (AIKI) Stock Up 1,400%?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AIKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AIkido Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address AIKI Company Calendar Today3/20/2023Next Earnings (Estimated)3/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AIKI CUSIPN/A CIK12239 Webwww.spherix.com Phone(112) 745-1374Fax703-992-9348Employees4Year Founded1967Price Target and Rating Average Stock Price Forecast$16.00 High Stock Price Forecast$16.00 Low Stock Price Forecast$16.00 Forecasted Upside/Downside+349.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-18.21% Return on Assets-16.94% Debt Debt-to-Equity RatioN/A Current Ratio29.54 Quick Ratio29.54 Sales & Book Value Annual Sales$10,000.00 Price / Sales1,952.66 Cash FlowN/A Price / Cash FlowN/A Book Value$19.27 per share Price / Book0.18Miscellaneous Outstanding Shares5,485,000Free Float5,013,000Market Cap$19.53 million OptionableNot Optionable Beta0.93 Social Links Key ExecutivesMr. Anthony C. Hayes Esq. (Age 54)CEO, Principal Financial Officer, Principal Accounting Officer & Director Comp: $960kMr. Darrell DotsonVP of Drug Devel. & Gen. CounselMr. Carlos AldaveroPres of Dominari FinancialKey CompetitorsSunshine BiopharmaNASDAQ:SBFMScience 37NASDAQ:SNCEiSpecimenNASDAQ:ISPCForte BiosciencesNASDAQ:FBRXVincerx PharmaNASDAQ:VINCView All CompetitorsInsidersKyle Michael WoolBought 5,000 shares on 12/19/2022Total: $17,950.00 ($3.59/share)Kyle Michael WoolBought 5,000 shares on 12/15/2022Total: $18,450.00 ($3.69/share)Anthony HayesBought 4,500 shares on 12/14/2022Total: $16,605.00 ($3.69/share)Anthony HayesBought 5,000 shares on 12/12/2022Total: $18,100.00 ($3.62/share)Anthony HayesBought 5,000 shares on 12/9/2022Total: $18,400.00 ($3.68/share)View All Insider Transactions AIKI Stock - Frequently Asked Questions Should I buy or sell AIkido Pharma stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AIkido Pharma in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AIKI shares. View AIKI analyst ratings or view top-rated stocks. What is AIkido Pharma's stock price forecast for 2023? 1 Wall Street research analysts have issued 1 year price objectives for AIkido Pharma's stock. Their AIKI share price forecasts range from $16.00 to $16.00. On average, they expect the company's stock price to reach $16.00 in the next twelve months. This suggests a possible upside of 349.4% from the stock's current price. View analysts price targets for AIKI or view top-rated stocks among Wall Street analysts. How have AIKI shares performed in 2023? AIkido Pharma's stock was trading at $3.28 on January 1st, 2023. Since then, AIKI stock has increased by 8.5% and is now trading at $3.56. View the best growth stocks for 2023 here. When is AIkido Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023. View our AIKI earnings forecast. When did AIkido Pharma's stock split? AIkido Pharma shares reverse split on Tuesday, June 7th 2022. The 1-17 reverse split was announced on Tuesday, June 7th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. What other stocks do shareholders of AIkido Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC), AIM ImmunoTech (AIM), Nuwellis (CHFS), Foresight Autonomous (FRSX), iBio (IBIO), Exela Technologies (XELA), Bionano Genomics (BNGO), Check-Cap (CHEK), Digital Ally (DGLY) and Purple Biotech (KTOV). What is AIkido Pharma's stock symbol? AIkido Pharma trades on the NASDAQ under the ticker symbol "AIKI." How do I buy shares of AIkido Pharma? Shares of AIKI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AIkido Pharma's stock price today? One share of AIKI stock can currently be purchased for approximately $3.56. How much money does AIkido Pharma make? AIkido Pharma (NASDAQ:AIKI) has a market capitalization of $19.53 million and generates $10,000.00 in revenue each year. The business services provider earns $-7,170,000.00 in net income (profit) each year or ($3.88) on an earnings per share basis. Does AIkido Pharma have any subsidiaries? The following companies are subsidiares of AIkido Pharma: Hoth Therapeutics.Read More How can I contact AIkido Pharma? AIkido Pharma's mailing address is ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020. The official website for the company is www.spherix.com. The business services provider can be reached via phone at (112) 745-1374, via email at investorrelations@spherix.com, or via fax at 703-992-9348. This page (NASDAQ:AIKI) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.